• Corpus ID: 441325

Metabolic syndrome.

@article{Minuk2005MetabolicS,
  title={Metabolic syndrome.},
  author={Howard Minuk},
  journal={Journal of insurance medicine},
  year={2005},
  volume={37 2},
  pages={
          155-7
        }
}
  • H. Minuk
  • Published 2005
  • Medicine
  • Journal of insurance medicine
This case study includes a sequence of underwriting events, as well as an overview of the mortality implications of this population health issue. 
View on PubMed
lib.ajaums.ac.ir
5,329 Citations
Highly Influential Citations
302
Background Citations
2,209
Methods Citations
174
Results Citations
77

Figures and Tables from this paper

5,329 Citations

Citation Type

Citation Type

Metabolic Syndrome and Hemoglobin Levels in Elderly Adults: The Invecchiare in Chianti Study
TLDR
To assess the association between metabolic syndrome (MetS) and hemoglobin levels in older adults, a large number of patients with MetS are randomly assigned to receive either a statin or a non-steroidal anti-inflammatory drug.
Metabolic syndrome in psoriatic arthritis patients: A cross‐sectional study
TLDR
The major objective of this study was to assess the prevalence of metabolic syndrome in Indian patients with psoriatic arthritis and to estimate the number of patients diagnosed with metabolic syndrome.
Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study
TLDR
This study highlights the need to understand more fully the rationale behind the continued use of these devices, as well as the importance of knowing when and how often these devices are used.
Mainstreaming the metabolic syndrome: a definitive definition
TLDR
This new definition should assist both researchers and clinicians in finding the right treatment for patients with complex medical conditions.
The impact of metabolic syndrome on long‐term outcomes of percutaneous nephrolithotomy (PCNL)
Study Type – Prognosis (cohort)
Metabolic Syndrome Components Correlation with Colorectal Neoplasms: A Systematic Review and a Meta-analysis
TLDR
This paper aims to provide a history of the field and some of the techniques used to develop and evaluate these techniques, as well as some examples of how they are used in practice and in the literature.
The echocardiographic manifestations of an urban, working class community with a high cardiovascular risk profile.
TLDR
To determine the prevalence of cardiovascular risk factors in the Phoenix community and their relationship to cardiac structural changes and genetic patterns, a large number of patients with a history of heart disease were screened for these factors.
Prevalence of metabolic syndrome among Australians with severe mental illness
Objective: To assess the prevalence of metabolic syndrome and its association with sociodemographic, clinical and lifestyle variables among Australian patients with a variety of psychiatric disorders.
Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome
The incidence of metabolic syndrome‐associated hepatocellular carcinoma (MS‐HCC) is increasing. However, the results following liver resection in this context have not been described in detail.
Association of androgenetic alopecia with metabolic syndrome in men: a community‐based survey
TLDR
This study investigates the association between factors related to metabolic syndrome, which is known to increase the risk of type 2 diabetes mellitus and cardiovascular disease, and androgenetic alopecia, and suggests that these factors may be related to each other.
...
...

References

SHOWING 1-10 OF 20 REFERENCES
Epidemiology of hypertriglyceridemia and cardiovascular disease.
  • M. Austin
  • Medicine, Biology
    The American journal of cardiology
  • 1999
Cardiovascular morbidity and mortality associated with the metabolic syndrome.
TLDR
The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from diferent studies.
Hepatic Lipase as a Focal Point for the Development and Treatment of Coronary Artery Disease
TLDR
By studying patients with dyslipidemia and CAD, strong evidence is provided that regression of coronary atherosclerosis results from at least two independent effects of lipid-lowering therapy on lipoprotein metabolism: the well known one that leads to changes in LDL-C and apo B levels, and a new pathway of HL-mediated improvement in LDL buoyancy.
Clustering of metabolic factors and coronary heart disease.
TLDR
Atherogenic risk factor clustering is common in both sexes, worsens with weight gain, and is associated with greatly increased risk of coronary disease risk in both males and women.
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.
TLDR
A risk algorithm has been developed for men aged 40 to 65 years which takes into account the independent risk factors of HDL cholesterol, LDL cholesterol, triglycerides, fibrinogen, age, systolic blood pressure, cigarette smoking, presence of diabetes mellitus and family history of myocardial infarction and angina pectoris.
Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study
TLDR
The low event rate in HOT Study patients is likely to result from pronounced blood pressure lowering, and is not explained by a lower risk profile than in previous controlled trials of antihypertensive treatment.
Lipotoxic diseases of nonadipose tissues in obesity
TLDR
It is proposed that an important function of leptin is to confine the storage of triglycerides (TG) to the adipocytes, while limiting TG storage in nonadipose tissues, suggesting that leptin controls the putative homeostatic system for intracellular TG.
The disease burden associated with overweight and obesity.
TLDR
A graded increase in the prevalence ratio (PR) was observed with increasing severity of overweight and obesity for all of the health outcomes except for coronary heart disease in men and high blood cholesterol level in both men and women.
The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease.
  • D. Maron
  • Medicine, Biology
    The American journal of cardiology
  • 2000
...
...